We are international
Donate
• myeloma tv TEXT SIZE   
webcasts from medical meetings    back

ASCO 2013: Dr. Ghobrial - Phase I study of TH-302, an investigational hypoxia-targeted drug, and dex in patients with RRMM

Irene M. Ghobrial, MD
Dana-Farber Cancer Institute
Boston, MA

06.11.13

Be the first to comment

 related articles